Works matching IS 02704137 AND DT 2019 AND VI 79 AND IP 3
Results: 11
Tumor‐infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 320, doi. 10.1002/pros.23738
- By:
- Publication type:
- Article
Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 312, doi. 10.1002/pros.23737
- By:
- Publication type:
- Article
Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 302, doi. 10.1002/pros.23736
- By:
- Publication type:
- Article
Death due to sepsis in patients diagnosed with prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 295, doi. 10.1002/pros.23735
- By:
- Publication type:
- Article
Urotensin II receptor expression in prostate cancer patients: A new possible marker.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 288, doi. 10.1002/pros.23734
- By:
- Publication type:
- Article
Clinical effectiveness of docetaxel for castration‐sensitive prostate cancer in a real‐world population‐based analysis.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 281, doi. 10.1002/pros.23733
- By:
- Publication type:
- Article
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 272, doi. 10.1002/pros.23732
- By:
- Publication type:
- Article
MicroRNAs as prognostic markers in prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 265, doi. 10.1002/pros.23731
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor therapy prescribed for non‐urologic diseases can modify PSA titers in urology patients.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 259, doi. 10.1002/pros.23730
- By:
- Publication type:
- Article
Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 244, doi. 10.1002/pros.23729
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 243, doi. 10.1002/pros.23670
- Publication type:
- Article